Effects of creatine supplementation in cystic fibrosis: Results of a pilot study

Journal of Cystic Fibrosis

Volumn 2, Issue 4, 2003, Pages 177-182

  Braegger, Christian P ^a   Schlattner, Uwe ^b   Wallimann, Theo ^b   Utiger, Anna ^a   Frank, Friederike ^a   Schaefer, Beat ^a   Heizmann, Claus W ^a   Sennhauser, Felix H ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Creatine kinase; Creatine supplementation; Cystic fibrosis transmembrane conductance regulator; Energy metabolism; Muscle strength

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE; CREATINE KINASE; CREATINE PHOSPHATE; ELECTROLYTE; PODIUM CREATINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; ARTICLE; ATHLETE; BODY WEIGHT; CELL COMPARTMENTALIZATION; CELL CULTURE; CHANNEL GATING; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DISEASE SEVERITY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; GENE MUTATION; HUMAN; LUNG FUNCTION; MALE; MUSCLE GROWTH; MUSCLE STRENGTH; MYALGIA; NEUROMUSCULAR DISEASE; PILOT STUDY; QUESTIONNAIRE; RESPIRATORY EPITHELIUM; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME; WELLBEING;

ADOLESCENT; CHILD; CREATINE; CYSTIC FIBROSIS; DIETARY SUPPLEMENTS; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PANCREATIC FUNCTION TESTS; PILOT PROJECTS; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0242404629     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-1993(03)00089-4     Document Type: Article

References (50)

1. Wyss M. Kaddurah-Daouk R. Creatine and creatinine metabolism Physiol Rev 80 2000 1107-1213
2. Wallimann T. Wyss M. Brdiczka D. Nicolay K. Eppenberger H.M. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis Biochem J 281 1992 21-40
3. Schlattner U. Forstner M. Eder M. Stachowiak O. Fritz-Wolf K. Wallimann T. Functional aspects of the X-ray structure of mitochondrial creatine kinase: a molecular physiology approach Mol Cell Biochem 184 1998 125-140
4. Rossi A.M. Eppenberger H.M. Volpe P. Cotrufo R. Wallimann T. Muscle-type MM-creatine kinase is specifically bound to sarcoplamsic reticulum and can support calcium uptake and regulate local APT/ADP ratios J Biol Chem 265 1990 5258-5266
5. Minajeva A. Ventura-Clapier R. Veksler V. Calcium uptake by cardiac sarcoplasmic reticulum ATPase in situ strongly depends on bound creatine kinase Pflüg Arch-Eur J Physiol 432 1996 904-912
6. Kay L. Nicolay K. Wieringa B. Saks V. Wallimann T. Direct evidence for the control of mitochondrial respiration by mitochondrial creatine kinase in oxidative muscle cells in situ J Biol Chem 275 2000 6937-6944
7. + -pump in apically permeabilzed A6 kidney cell epithelia: role of creatine kinase Am J Physiol 272 1997 C697-C706
8. +-ATPase on the apical membrane and the tubulovesicular system of parietal cells Biochem J 311 1995 445-451
9. Schlattner U. Möckli N. Speer O. Werner S. Wallimann T. Creatine kinase and creatine transporter in normal, wounded, and diseased murine skin J Invest Dermatol 118 2002 416-423
10. Keller T.C. Gordon P.V. Subcellular localization of a cytoplasmic and a mitochondrial isozyme of creatine kinase in intestinal epithelial cells Cell Motil Cytoskel 19 1991 169-179
11. Gordon P.V. Keller T.C. Functional coupling to brush border creatine kinase imparts a selective energetic advantage to contractile ring myosin in intestinal epithelial cells Cell Motil Cytoskel 21 1992 38-44
12. Sistermans E.A. de Kok Y.J. Peters W. Ginsel L.A. Jap P.H. Wieringa B. Tissue- and cell-specific distribution of creatine kinase B: a new and highly specific monoclonal antibody for use in immunohistochemistry Cell Tissue Res 280 1995 435-446
13. Ikeda K. Localization of brain type creatine kinase in kidney epithelial cell subpopulations in rat Experientia 44 1988 734-735
14. Barrantes F.J. Mieskes G. Wallimann T. Creatine kinase activity in the Torpedo electrocyte and in the non-receptor, peripheral v proteins from acetylcholine receptor-rich membranes Proc Natl Acad Sci USA 80 1983 5440-5444
15. --creatine transporter: functional, molecular characterization and localization J Physiol 545 2002 133-144
16. Harris R.C. Söderlund K. Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation Clin Sci 83 1992 367-374
17. Balsom P.D. Soderlund K. Ekblom B. Creatine in humans with special reference to creatine supplementation Sports Med 18 1994 268-280
18. Vandenberghe K. Goris M. Van Hecke P. van Leemputte M. Vangerven L. Hespel P. Long-term creatine intake is beneficial to muscle performance during resistance training J Appl Physiol 83 1997 2055-2063
19. Walter M.C. Lochmuller H. Reilich P. Klopstock T. Huber R. Hartard M. et al. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study Neurology 54 2000 1848-1850
20. Klopstock T. Querner V. Schmidt F. Gekeler F. Walter M. Hartard M. et al. A placebo-controlled crossover trial of creatine in mitochondrial diseases Neurology 55 2000 1748-1751
21. Tarnopolsky M. Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease Neurology 52 1999 854-857
22. 2+ handling and survival in mdx skeletal muscle cells FEBS Lett 439 1998 357-362
23. Passaquin A.C. Renard M. Kay L. Challet C. Mokhtarian A. Wallimann T. et al. Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice Neuromuscul Disord 12 2002 174-182
24. Klivenyi P. Ferrante R.J. Matthews R.T. Bogdanov M.B. Klein A.M. Andreassen O.A. et al Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis Nat Med 5 1999 347-350
25. Matthews R.T. Yang L. Jenkins B.G. Ferrante R.J. Rosen B.R. Kaddurah-Daouk R. et al. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease J Neurosci 18 1998 156-163
26. Tarnopolsky M.A. Beal M.F. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders Ann Neurol 49 2001 561-574
27. Durie P.R. Pencharz P.B. A rational approach to the nutritional care of patients with cystic fibrosis J Roy Soc Med 82 1988 11-20
28. Welsh M.J. Smith A.E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis Cell 73 1993 1251-1254
29. Gadsby D.C. Nairn A.C. Regulation of CFTR channel gating Trends Biochem Sci 9 1994 513-518
30. Hwang T.C. Nagel G. Nairn A.C. Gadsby D.C. Regulation of the gating of cystic fibrosis transmembrane conductance regulator Cl- channels by phosphorylation and ATP hydrolysis Proc Natl Acad Sci USA 91 1994 4698-4702
31. Friedman D.L. Roberts R. Purification and localization of brain-type creatine kinase in sodium chloride transporting epithelia of the spiny dogfish J Biol Chem 267 1992 4270-4276
32. Hallows K.R. McCane J.E. Kemp B.E. Witters L.A. Foskett J.K. Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells J Biol Chem 278 2003 998-1004
33. Best O.G. Treharne K.J. Goddard C. Colledge W. Muimo R. Mehta A. Novel regulation of the nucleotide generator NDPK by the AMP-activated protein kinase. Second International Symposium on AMPK-activated protein kinase. Book of Abstracts. Dundee, UK, 2002:27
34. Bye M.R. Ewig J.M. Quittel M.L. Cystic fibrosis Lung 172 1994 251-270
35. Stucki G. Schonbachler J. Bruhlmann P. Mariacher S. Stoll T. Michel B.A. Does a muscle strength index provide complementary information to traditional disease activity variables in patients with rheumatoid arthritis? J Rheumatol 21 1994 2200-2205
36. Stoll T. Brühlmann P. Stucki G. Seifert B. Michel B.A. Muscle strenght assessment in poly- and dermatomyositis: evaluation of the reliability and clinical use of a new, quantitative, easy applicable method J Rheumatol 22 1995 473-477
37. Stoll T. Huber E. Seifert B. Michel A. Stucki G. Maximal isometric muscle strength: normative values and gender-specific relation to age Clin Rheumatol 19 2000 105-113
38. Merten M.D. Kammouni W. Renaud W. Birg F. Mattei M.G. Figarella C. A transformed human tracheal gland cell line, MM-39, that retains serous secretory functions Am J Respir Cell Mol Biol 15 1996 520-528
39. Emery N. Place G.A. Dodd S. Lhermitte M. David G. Lamblin G. et al. Mucous and serous secretion of human bronchial epithelial cells in secondary culture Am J Respir Cell Mol Biol 12 1995 130-141
40. Wallimann T. Schlösser T. Eppenberger H.M. Function of M-line bound creatine kinase as an intramyofibrillar ATP regenerator at the receiving end of the phosphoryl-creatine shuttle in muscle J Biol Chem 259 1984 5238-5246
41. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248-254
42. Joseph J. Cardesa A. Carreras J. Creatine kinase activity and isoenzymes in lung, colon and liver carcinomas Br J Cancer 76 1997 600-605
43. Greenhaff P.L. The nutritional biochemistry of creatine J Nutr Biochem 8 1997 610-618
44. Terjung R.L. Clarkson P. Eichner E.R. Greenhaff P.L. Hespel P.J. Israel R.G. et al. American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation Med Sci Sport Exer 32 2000 706-717
45. Wallimann T. Schlattner U. Guerrero L. Dolder M. The phosphocreatine circuit and creatine supplementation, both come of age In: Mori A. Ishida M. Clark J.F. Guanidino (Eds.), Compounds in Biology and Medicine 1999 117-129 Blackwell Science Asia Pty Ltd
46. van Leemputte M. Vandenberghe K. Hespel P. Shortening of muscle relaxation time after creatine loading J Appl Physiol 86 1999 840-844
47. Volek J.S. Duncan N.D. Mazzetti S.A. Staron R.S. Putukian M. Gomez A.L. et al. Performance and muscle fiber adaptations to creatine supplementation an heavy resistance training Med Sci Sport Exer 31 1999 1147-1156
48. Hespel P. OP 't Eijnde B. Van Leemputte M. Urso B. Greenhaff P. Labarque V. et al. Oral creatine supplementation facilitates rehabilitation of disuse atrophy and alters expression of muscle myogenic factors J Physiol 536 2001 625-633
49. Dorin J.R. Altoin E.W.F.W. Porteous D.J. Mouse models for cystic fibrosis In: Dodge J.J. Brock D.J.H. Widdicombe J.E. (Eds.), Cystic fibrosis-current topics 2 1994 3-31 J Wiley
50. Zhou L. Dey C.R. Wert S.E. DuVall M.D. Frizzell R.A. Whitsett J.A. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR Science 266 1994 1705-1708